RecruitingNCT06411470

Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis


Sponsor

Changhai Hospital

Enrollment

600 participants

Start Date

Apr 20, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators plan to collect throat swabs, saliva, feces and serum samples from pancreatic cancer patients, chronic pancreatitis patients and healthy people and clarify the characteristics of oral flora and serum metabolome of pancreatic cancer patients.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study analyzes the gut microbiome (bacteria living in your digestive system) and blood metabolites in patients with pancreatic cancer or chronic pancreatitis (long-term inflammation of the pancreas), comparing them to healthy people. The goal is to discover biological markers that might help with earlier diagnosis or better treatment. **You may be eligible if...** - You have been diagnosed with pancreatic cancer (pancreatic ductal adenocarcinoma) - You have been diagnosed with chronic pancreatitis with clear signs on imaging (such as calcifications on CT scan) - Or you are a healthy person without pancreatic disease (for the comparison group) **You may NOT be eligible if...** - You are pregnant - You have a blood clotting disorder that makes blood tests unsafe - You have used antibiotics or probiotics within the past 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Changhai Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06411470


Related Trials